Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
blood diseases
Research
Sickle cell gene therapy process may cause cancerous mutations
A study on patients in a clinical trial for sickle cell disease suggests a pre-treatment process might cause cancerous mutations in blood stem cells.
Helen Floersh
Nov 20, 2023 9:10am
One shot to cure sickle cell? Scientists give it a try with mRNA
Jul 28, 2023 11:12am
Rocket's hematology programs blast off toward regulators
May 19, 2023 11:01am
Hemab uses $135M series B to target neglected blood disorders
Feb 21, 2023 4:07am
AstraZeneca's Alexion hopes to extend dominance in PNH
Dec 16, 2022 7:25am
Sanofi preps hemophilia duo for patients seeking normalcy
Jul 10, 2022 9:45am
